Exact Mass: 556.3036

Exact Mass Matches: 556.3036

Found 112 metabolites which its exact mass value is equals to given mass value 556.3036, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cucurbitacin_E

[(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H44O8 (556.3036)


Cucurbitacin E is a cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin E is a natural product found in Cucurbita foetidissima, Helicteres angustifolia, and other organisms with data available. A cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex.

   

Cucurbitacin E

6-{4,13-dihydroxy-1,6,6,11,15-pentamethyl-5,17-dioxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,7-dien-14-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetic acid

C32H44O8 (556.3036)


   

Dronedarone

N-(2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide

C31H44N2O5S (556.2971)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Dronedarone (SR 33589), a derivative of amiodarone (HY-14187), is a class III antiarrhythmic agent for the study of atrial fibrillation (AF) and atrial flutter. Dronedarone is a potent blocker of multiple ion currents, including potassium current, sodium current, and L-type calcium current, and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors. Dronedarone is a substrate for and a moderate inhibitor of CYP3A4[1].

   

Chaetoglobosin L

Chaetoglobosin L

C34H40N2O5 (556.2937)


   

Chaetoglobosin K

Chaetoglobosin K

C34H40N2O5 (556.2937)


   

chaetoglobosin M

chaetoglobosin M

C34H40N2O5 (556.2937)


   

Dronedarone

Dronedarone

C31H44N2O5S (556.2971)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; INTERNAL_ID 2181 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2855 INTERNAL_ID 2181; CONFIDENCE standard compound Dronedarone (SR 33589), a derivative of amiodarone (HY-14187), is a class III antiarrhythmic agent for the study of atrial fibrillation (AF) and atrial flutter. Dronedarone is a potent blocker of multiple ion currents, including potassium current, sodium current, and L-type calcium current, and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors. Dronedarone is a substrate for and a moderate inhibitor of CYP3A4[1].

   
   

HAVANENSIN TRIACETATE

HAVANENSIN TRIACETATE

C32H44O8 (556.3036)


   

Cucurbitacin E

acetic acid [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester

C32H44O8 (556.3036)


Cucurbitacin e is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin e is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin e is a bitter tasting compound found in cucumber, muskmelon, and watermelon, which makes cucurbitacin e a potential biomarker for the consumption of these food products. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex. Cucurbitacin E is a natural compound which from Cucurbitaceae plants. Cucurbitacin E significantly suppresses the activity of the cyclin B1/CDC2 complex.

   

(4R)-4-(3,4-dihydroxy-6-{(2S,4R,6S)-4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl[1,3]dioxan-2-yl}-2-methylbenzyl)-4,5-dihydro-5,5-dimethylfuran-2(3H)-one|lycifuranone C

(4R)-4-(3,4-dihydroxy-6-{(2S,4R,6S)-4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl[1,3]dioxan-2-yl}-2-methylbenzyl)-4,5-dihydro-5,5-dimethylfuran-2(3H)-one|lycifuranone C

C32H44O8 (556.3036)


   

12-O-(2E,4E-decadienoyl)-4-deoxy-16-hydroxyphorbol-13-acetate

12-O-(2E,4E-decadienoyl)-4-deoxy-16-hydroxyphorbol-13-acetate

C32H44O8 (556.3036)


   

lindbergin A

lindbergin A

C32H44O8 (556.3036)


   

5beta,6beta-epoxy-4beta-hydroxy-27-(1-formyloxy-1-methylethoxy)-1-oxo-witha-2,24-dienolide

5beta,6beta-epoxy-4beta-hydroxy-27-(1-formyloxy-1-methylethoxy)-1-oxo-witha-2,24-dienolide

C32H44O8 (556.3036)


   

Wikstrotoxin B

Wikstrotoxin B

C32H44O8 (556.3036)


   

prostratin Q

prostratin Q

C32H44O8 (556.3036)


   

[2-(2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

[2-(2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-6-methyl-3-oxohept-4-en-2-yl] acetate

C32H44O8 (556.3036)


   

Elaphogayanin B

Elaphogayanin B

C32H44O8 (556.3036)


   

Korksaeure-mono-(3)desacetylcinobufagylester

Korksaeure-mono-(3)desacetylcinobufagylester

C32H44O8 (556.3036)


   

12-O-(4Z,7Z)-deca-4,7-dienoylphorbol-13-acetate

12-O-(4Z,7Z)-deca-4,7-dienoylphorbol-13-acetate

C32H44O8 (556.3036)


   

30-Methyloscillatoxin D

30-Methyloscillatoxin D

C32H44O8 (556.3036)


   

isocucurbitacin E

isocucurbitacin E

C32H44O8 (556.3036)


   

Ala Arg Asp Pro Val

Ala Arg Asp Pro Val

C23H40N8O8 (556.2969)


   

C32H44O8_Estra-1,5-diene-3,11-dione, 17-[(1R,3E)-1-(acetyloxy)-5-hydroxy-1,5-dimethyl-2-oxo-3-hexen-1-yl]-2,16-dihydroxy-4,4,9,14-tetramethyl-, (9beta,10alpha,16alpha,17beta)

NCGC00386015-01_C32H44O8_Estra-1,5-diene-3,11-dione, 17-[(1R,3E)-1-(acetyloxy)-5-hydroxy-1,5-dimethyl-2-oxo-3-hexen-1-yl]-2,16-dihydroxy-4,4,9,14-tetramethyl-, (9beta,10alpha,16alpha,17beta)-

C32H44O8 (556.3036)


   

Glu Pro Arg Arg

(4S)-4-amino-5-[(2S)-2-{[(1S)-4-carbamimidamido-1-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}butyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C22H40N10O7 (556.3081)


   

Glu Arg Pro Arg

(4S)-4-amino-4-{[(2S)-5-carbamimidamido-1-[(2S)-2-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}pyrrolidin-1-yl]-1-oxopentan-2-yl]carbamoyl}butanoic acid

C22H40N10O7 (556.3081)


   

Glu Arg Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H40N10O7 (556.3081)


   

Pro Glu Arg Arg

(4S)-4-{[(1S)-4-carbamimidamido-1-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}butyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C22H40N10O7 (556.3081)


   

Pro Arg Glu Arg

(4S)-4-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}-4-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanoic acid

C22H40N10O7 (556.3081)


   

Pro Arg Arg Glu

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]pentanedioic acid

C22H40N10O7 (556.3081)


   

Pro Arg Val Trp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Pro Arg Trp Val

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Pro Val Arg Trp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Pro Val Trp Arg

(2S)-5-carbamimidamido-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]pentanoic acid

C27H40N8O5 (556.3122)


   

Pro Trp Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Pro Trp Val Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]pentanoic acid

C27H40N8O5 (556.3122)


   

Arg Glu Pro Arg

(4S)-4-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-[(2S)-2-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C22H40N10O7 (556.3081)


   

Arg Glu Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carboxybutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H40N10O7 (556.3081)


   

Arg Pro Glu Arg

(4S)-4-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl}butanoic acid

C22H40N10O7 (556.3081)


   

Arg Pro Arg Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]pentanedioic acid

C22H40N10O7 (556.3081)


   

Arg Pro Val Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Arg Pro Trp Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Arg Arg Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C22H40N10O7 (556.3081)


   

Arg Arg Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C22H40N10O7 (556.3081)


   

Arg Val Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Arg Val Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

Arg Trp Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Arg Trp Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

Val Pro Arg Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Val Pro Trp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H40N8O5 (556.3122)


   

Val Arg Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C27H40N8O5 (556.3122)


   

Val Arg Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

Val Trp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C27H40N8O5 (556.3122)


   

Val Trp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

Trp Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Trp Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C27H40N8O5 (556.3122)


   

Trp Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C27H40N8O5 (556.3122)


   

Trp Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

Trp Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C27H40N8O5 (556.3122)


   

Trp Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C27H40N8O5 (556.3122)


   

ARDPV

Ala Arg Asp Pro Val

C23H40N8O8 (556.2969)


   

(-)-Euphomine

(-)-Euphomine

C32H44O8 (556.3036)


   

PI(P-16:0/0:0)

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

C25H49O11P (556.3012)


   

LPI O-16:1

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

C25H49O11P (556.3012)


   

[(E)-6-[(9R,13R,14S,16R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

[(E)-6-[(9R,13R,14S,16R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H44O8 (556.3036)


   

ELATERIN, ALPHA

ELATERIN, ALPHA

C32H44O8 (556.3036)


   

rel-12-O-(4Z,7Z)-Deca-4,7-dienoylphorbol-13-acetate

rel-12-O-(4Z,7Z)-Deca-4,7-dienoylphorbol-13-acetate

C32H44O8 (556.3036)


A natural product found in Pimelea elongata.

   

[(E,6R)-6-[(8S,9R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

[(E,6R)-6-[(8S,9R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate

C32H44O8 (556.3036)


   

2-[[3-acetyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-acetyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C28H47NO8P+ (556.3039)


   

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-myo-inositol)

C25H49O11P (556.3012)


   
   

LPI P-16:0 or LPI O-16:1

LPI P-16:0 or LPI O-16:1

C25H49O11P (556.3012)


   

ST 26:5;O2;GlcA

ST 26:5;O2;GlcA

C32H44O8 (556.3036)


   

ST 26:6;O3;Hex

ST 26:6;O3;Hex

C32H44O8 (556.3036)


   

ST 29:2;O5;S

ST 29:2;O5;S

C29H48O8S (556.307)


   

2-methyl-5-oxooxolan-3-yl (2r,3s,6s,7s,9r)-2-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

2-methyl-5-oxooxolan-3-yl (2r,3s,6s,7s,9r)-2-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

C32H44O8 (556.3036)


   

(3e,6s)-6-[(1r,2r,3as,3bs,9as,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6s)-6-[(1r,2r,3as,3bs,9as,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)


   

3-hydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-5'',7,10-trioxo-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-4-yl acetate

3-hydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-5'',7,10-trioxo-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-4-yl acetate

C32H44O8 (556.3036)


   

17-ethyl-6,21-dihydroxy-19-[1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

17-ethyl-6,21-dihydroxy-19-[1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

C34H40N2O5 (556.2937)


   

(1s,3z,6r,7z,9s,11z,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

(1s,3z,6r,7z,9s,11z,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

C34H40N2O5 (556.2937)


   

(4r)-4-({3,4-dihydroxy-6-[(2s,4r,6s)-4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl-1,3-dioxan-2-yl]-2-methylphenyl}methyl)-5,5-dimethyloxolan-2-one

(4r)-4-({3,4-dihydroxy-6-[(2s,4r,6s)-4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl-1,3-dioxan-2-yl]-2-methylphenyl}methyl)-5,5-dimethyloxolan-2-one

C32H44O8 (556.3036)


   

(3e,6s)-6-[(1r,2r,3as,3bs,9ar,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6s)-6-[(1r,2r,3as,3bs,9ar,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)


   

(1s,3s,3'r,3as,4s,4''s,5's,5ar,9as,11as)-3-hydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-5'',7,10-trioxo-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-4-yl acetate

(1s,3s,3'r,3as,4s,4''s,5's,5ar,9as,11as)-3-hydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-5'',7,10-trioxo-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-4-yl acetate

C32H44O8 (556.3036)


   

2-methyl-5-oxooxolan-3-yl 2-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

2-methyl-5-oxooxolan-3-yl 2-[5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

C32H44O8 (556.3036)


   

(1r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

(1r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

C34H40N2O5 (556.2937)


   

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r,19s)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

C34H40N2O5 (556.2937)


   

2-[(2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene)amino]-3-methylbutanoic acid

2-[(2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene)amino]-3-methylbutanoic acid

C23H40N8O8 (556.2969)


   

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)


   

(1r,3br,4s,5r,5as,7r,9s,9ar,9br,11as)-4,7-bis(acetyloxy)-1-(furan-3-yl)-9-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3br,4s,5r,5as,7r,9s,9ar,9br,11as)-4,7-bis(acetyloxy)-1-(furan-3-yl)-9-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C32H44O8 (556.3036)


   

12,14-bis(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

12,14-bis(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

C32H44O8 (556.3036)


   

2-{[(6r)-6-[(1s)-1-[(1s,2r,6s,7r,9r,11s,12s,15r,16s)-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-15-yl]ethyl]-4-methyl-2-oxo-5,6-dihydropyran-3-yl]methoxy}propan-2-yl formate

2-{[(6r)-6-[(1s)-1-[(1s,2r,6s,7r,9r,11s,12s,15r,16s)-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-15-yl]ethyl]-4-methyl-2-oxo-5,6-dihydropyran-3-yl]methoxy}propan-2-yl formate

C32H44O8 (556.3036)


   

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C32H44O8 (556.3036)


   

(3s,3ar,4s,6s,6ar,10s,13r,17as)-4-ethyl-1,6,13-trihydroxy-3-[(1r)-1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

(3s,3ar,4s,6s,6ar,10s,13r,17as)-4-ethyl-1,6,13-trihydroxy-3-[(1r)-1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

C34H40N2O5 (556.2937)


   

4-ethyl-1,6,13-trihydroxy-3-[1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

4-ethyl-1,6,13-trihydroxy-3-[1-(1h-indol-3-yl)ethyl]-10,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

C34H40N2O5 (556.2937)


   

(1r,3br,4s,5r,5as,7r,9s,9ar,9br,11as)-7,9-bis(acetyloxy)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

(1r,3br,4s,5r,5as,7r,9s,9ar,9br,11as)-7,9-bis(acetyloxy)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C32H44O8 (556.3036)


   

2-hexanoyl-6-[(3-hexanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

2-hexanoyl-6-[(3-hexanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C32H44O8 (556.3036)


   

13-(acetyloxy)-1-hydroxy-8,12-bis(hydroxymethyl)-4,12,15-trimethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl deca-2,4-dienoate

13-(acetyloxy)-1-hydroxy-8,12-bis(hydroxymethyl)-4,12,15-trimethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl deca-2,4-dienoate

C32H44O8 (556.3036)


   

(2r,3r)-2-methyl-5-oxooxolan-3-yl (2r,3s,6s,7s,9r)-2-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

(2r,3r)-2-methyl-5-oxooxolan-3-yl (2r,3s,6s,7s,9r)-2-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-3,9,11,11-tetramethyl-8-oxo-1-oxaspiro[5.5]undec-4-ene-7-carboxylate

C32H44O8 (556.3036)


   

4-[(3,4-dihydroxy-6-{4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl-1,3-dioxan-2-yl}-2-methylphenyl)methyl]-5,5-dimethyloxolan-2-one

4-[(3,4-dihydroxy-6-{4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-pentyl-1,3-dioxan-2-yl}-2-methylphenyl)methyl]-5,5-dimethyloxolan-2-one

C32H44O8 (556.3036)


   

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

(1s,3e,6r,7e,9s,11e,13r,14s,16r,17s,18r)-17-ethyl-6,21-dihydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-3,7,11,20-tetraene-2,5-dione

C34H40N2O5 (556.2937)


   

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

6-{2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)


   

(1r,2r,6s,10r,11r,12s,13s,14r,15r)-13-(acetyloxy)-1-hydroxy-8,12-bis(hydroxymethyl)-4,12,15-trimethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2e,4e)-deca-2,4-dienoate

(1r,2r,6s,10r,11r,12s,13s,14r,15r)-13-(acetyloxy)-1-hydroxy-8,12-bis(hydroxymethyl)-4,12,15-trimethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl (2e,4e)-deca-2,4-dienoate

C32H44O8 (556.3036)


   

16-(acetyloxy)-10-hydroxy-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid

16-(acetyloxy)-10-hydroxy-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid

C32H44O8 (556.3036)


   

(2r,4s,7r,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-10-hydroxy-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid

(2r,4s,7r,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-10-hydroxy-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid

C32H44O8 (556.3036)


   

(1s,7z,9s,11z,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

(1s,7z,9s,11z,13r,14s,16r,17s,18r,19s)-17-ethyl-21-hydroxy-19-[(1r)-1-(1h-indol-3-yl)ethyl]-7,9,16-trimethyl-15-oxa-20-azatetracyclo[11.8.0.0¹,¹⁸.0¹⁴,¹⁶]henicosa-7,11,20-triene-2,5,6-trione

C34H40N2O5 (556.2937)


   

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

(1r,2r,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-5-one

C32H44O8 (556.3036)


   

(1s,2r,4r,6s,7s,10r,11s,12s,14r,16s,18r)-12,14-bis(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

(1s,2r,4r,6s,7s,10r,11s,12s,14r,16s,18r)-12,14-bis(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

C32H44O8 (556.3036)


   

(2s)-2-{[(2s)-2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene]amino}-3-methylbutanoic acid

(2s)-2-{[(2s)-2-{[(3-{3,4-dihydroxy-5-[1-(c-hydroxycarbonimidoyl)-2-iminoimidazolidin-4-yl]pentyl}-5-hydroxy-6-methyl-1,2,3,6-tetrahydropyrazin-2-yl)(hydroxy)methylidene]amino}-1-hydroxypropylidene]amino}-3-methylbutanoic acid

C23H40N8O8 (556.2969)


   

(3e,6r)-6-[(1r,2r,3as,3bs,5as,9as,9bs,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6r)-6-[(1r,2r,3as,3bs,5as,9as,9bs,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,5ah,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)


   

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,6-dihydroxy-4-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

(4s)-2-hexanoyl-6-[(3-hexanoyl-2,6-dihydroxy-4-methoxyphenyl)methyl]-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)cyclohexa-2,5-dien-1-one

C32H44O8 (556.3036)


   

(3e,6r)-6-[(1r,2r,3as,3bs,9as,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6r)-6-[(1r,2r,3as,3bs,9as,9br,11ar)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C32H44O8 (556.3036)